Main Topic Area
All Topic Areas
1 - 10 of 993 more >>
Articles
1 - 5 of 177 more >>
- Chagas disease
Chagas disease (also called American trypanosomiasis) is a mammalian disease occurring only in the Americas. It is caused by the protozoan Trypanosoma cruzi, one of the kinetoplastid flagellates, transmitted to humans by triatomine insects known in the different countries as assassin bug, vinchuca, kissing bug, chipo, barbeiro, etc. Common triatomine vector species for trypanosomiasis belong to the genera Triatoma, Rhodnius, and Panstrongylus. The most common transmitting species are Triatoma...
Wikipedia
- Alexander Disease Information Page
Alexander disease is a rare, genetically determined degenerative disorder of the central nervous system. It is one of a group of disorders known as the leukodystrophies, diseases that result from imperfect growth or development of the myelin sheath, the fatty covering that acts as an insulator around nerve fibers in the brain. Myelin, which lends its color to the "white matter" of the brain, is a complex substance made up of at least ten different chemicals. Each of the leukodystrophies affects...
National Institute of Neurological Disorders and Stroke
- Alpers' Disease Information Page
Alpers' disease is a rare, genetically determined disease of the brain that causes progressive degeneration of grey matter in the cerebrum. The first sign of the disease usually begins early in life with convulsions. Other symptoms are developmental delay, progressive mental retardation, hypotonia (low muscle tone), spasticity (stiffness of the limbs), dementia, and liver conditions such as jaundice and cirrhosis that can lead to liver failure. Optic atrophy may also occur, often causing...
National Institute of Neurological Disorders and Stroke
- Alzheimer's Disease Information Page
Alzheimer's disease (AD) is a progressive, neurodegenerative disease characterized in the brain by abnormal clumps (amyloid plaques) and tangled bundles of fibers (neurofibrillary tangles) composed of misplaced proteins. Age is the most important risk factor for AD; the number of people with the disease doubles every 5 years beyond age 65. Three genes have been discovered that cause early onset (familial) AD. Other genetic mutations that cause excessive accumulation of amyloid protein are...
National Institute of Neurological Disorders and Stroke
- Von Hippel-Lindau disease (VHL) Information Page
von Hippel-Lindau disease (VHL) is a rare, genetic multi-system disorder characterized by the abnormal growth of tumors in certain parts of the body (angiomatosis). The tumors of the central nervous system (CNS) are benign and are comprised of a nest of blood vessels and are called hemangioblastomas (or angiomas in the eye). Hemangioblastomas may develop in the brain, the retina of the eyes, and other areas of the nervous system. Other types of tumors develop in the adrenal glands, the kidneys,...
National Institute of Neurological Disorders and Stroke
Organizations
1 - 5 of 54 more >>
- Raynaud's Foundation - http://members.aol.com/raynauds/index.htm
- Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion -
- Celiac Disease Foundation - http://www.celiac.org/
- Parkinson's Disease Foundation - http://www.parkinsons-foundation.org/
- Lyme Disease Foundation, Inc. - http://www.lyme.org/
News
1 - 5 of 8213 more >>
- Space-Age Bandage Device Lets Doctors Monitor Patients With Raynaud's Disease
ScienceDaily - Fri, 02 Feb 2007 04:00 EST
- Team Field Tests Monitor To Characterize Raynaud's Disease
MedicalNewsToday - Sun, 04 Feb 2007 08:00 EST
- Health Tip: Understanding Raynaud's Disease
MedicineNet - Mon, 29 Jan 2007 07:00 EST
- Journal Sleep: OSA Increasingly Associated With Cardiovascular Disease
MedicalNewsToday - Wed, 07 Mar 2007 12:00 EST
- Single Genetic Defect Causes Early Heart Disease
ScienceDaily - Tue, 06 Mar 2007 04:00 EST
Clinical Trials
1 - 5 of 4762 more >>
- A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon
ClinicalTrials.gov Identifier: NCT00577304 - Recruiting
Raynaud's Disease; Raynaud's Disease Secondary to Scleroderma; Raynaud's Disease Secondary to Other Autoimmune Disease
- Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon
ClinicalTrials.gov Identifier: NCT00378521 - Completed
Raynaud's Disease; Raynaud's Disease Secondary to Scleroderma; Raynaud's Disease Secondary to Autoimmune Disease
- Safety, Tolerability and Pharmcodynamic Profile of Oral 2101 Once Daily for up to 14 Days in Secondary Raynaud's Disease
ClinicalTrials.gov Identifier: NCT00528242 - Recruiting
Secondary Raynaud's Disease
- St. John's Wort in the Treatment of Raynaud's Phenomenon.
ClinicalTrials.gov Identifier: NCT00351117 - Not yet recruiting
Raynaud's Disease
- Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon
ClinicalTrials.gov Identifier: NCT00048776 - Completed
Raynaud's Disease

Not Signed In -

